ScoreWhy is Bal Pharma Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.12 times
- Poor long term growth as Net Sales has grown by an annual rate of 10.42% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.12 times
- The company has been able to generate a Return on Equity (avg) of 6.77% signifying low profitability per unit of shareholders funds
2
Negative results in Dec 24
- PBT LESS OI(Q) At Rs 0.06 cr has Fallen at -94.87%
- INTEREST(Q) At Rs 5.01 cr has Grown at 37.26%
- NET SALES(Q) Lowest at Rs 73.15 cr
3
Stock is technically in a Mildly Bearish range
- The stocks Bollinger Band and KST technical factors are also Bearish
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bal Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bal Pharma
2.32%
0.04
58.45%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.42%
EBIT Growth (5y)
41.84%
EBIT to Interest (avg)
1.17
Debt to EBITDA (avg)
7.30
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.46
Tax Ratio
11.45%
Dividend Payout Ratio
25.66%
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
7.49%
ROE (avg)
6.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
2.38
EV to EBIT
13.51
EV to EBITDA
9.33
EV to Capital Employed
1.48
EV to Sales
0.93
PEG Ratio
0.22
Dividend Yield
1.17%
ROCE (Latest)
10.81%
ROE (Latest)
11.14%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-9What is not working for the Company
PBT LESS OI(Q)
At Rs 0.06 cr has Fallen at -94.87%
INTEREST(Q)
At Rs 5.01 cr has Grown at 37.26%
NET SALES(Q)
Lowest at Rs 73.15 cr
Loading Valuation Snapshot...
Here's what is not working for Bal Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 0.06 cr has Fallen at -94.87%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
At Rs 73.15 cr has Fallen at -10.42%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Interest - Quarterly
At Rs 5.01 cr has Grown at 37.26%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Net Sales - Quarterly
Lowest at Rs 73.15 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Interest - Quarterly
Highest at Rs 5.01 cr
in the last five quarters and Increased by 37.26 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
